MML Investors Services’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,047
Closed -$28K 2357
2023
Q1
$28K Hold
3,047
﹤0.01% 2008
2022
Q4
$36K Hold
3,047
﹤0.01% 2130
2022
Q3
$65K Hold
3,047
﹤0.01% 2038
2022
Q2
$74K Hold
3,047
﹤0.01% 1995
2022
Q1
$152K Hold
3,047
﹤0.01% 1998
2021
Q4
$214K Buy
3,047
+167
+6% +$14.1K ﹤0.01% 1889
2021
Q3
$269K Hold
2,880
﹤0.01% 1695
2021
Q2
$289K Sell
2,880
-467
-14% -$45.5K ﹤0.01% 1638
2021
Q1
$312K Buy
3,347
+2,717
+431% +$275K ﹤0.01% 1496
2020
Q4
$52K Buy
+630
New +$53.7K ﹤0.01% 1653

Other funds holding VBIV

MML Investors Services's VBIV Position: Q2 2023 in Review

MML Investors Services sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 3,047 shares — an estimated $28K sold.

MML Investors Services first reported a position in VBIV in Q4 2020 and held it in 10 quarters. The position peaked at $312K in Q1 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • MML Investors Services reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • MML Investors Services sold 3,047 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $28K.
  • MML Investors Services first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 10 quarters.
  • MML Investors Services's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $312K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on MML Investors Services's 13F filing for Q2 2023, filed 14 Aug 2023.